4-amino-1-[(1S,6R,8R,10S,15R,17R,19S,24R,26R,28S,33R,35R,37S,42R,44R,46S,51R,53R,55S,60R,62R)-17,26,35,44,53,62-hexakis(4-amino-2-oxopyrimidin-1-yl)-3,12,21,30,39,48,57-heptahydroxy-3,12,21,30,39,48,57-heptaoxo-2,4,7,11,13,16,20,22,25,29,31,34,38,40,43,47,49,52,56,58,61-henicosaoxa-3λ5,12λ5,21λ5,30λ5,39λ5,48λ5,57λ5-heptaphosphaoctacyclo[58.3.0.06,10.015,19.024,28.033,37.042,46.051,55]trihexacontan-8-yl]pyrimidin-2-one | 116113-41-8

分子结构分类

有机化合物 - 核苷、核苷酸和类似物 - （3'->5'）-二核苷酸和类似物

中文名称

——

中文别名

——

英文名称

4-amino-1-[(1S,6R,8R,10S,15R,17R,19S,24R,26R,28S,33R,35R,37S,42R,44R,46S,51R,53R,55S,60R,62R)-17,26,35,44,53,62-hexakis(4-amino-2-oxopyrimidin-1-yl)-3,12,21,30,39,48,57-heptahydroxy-3,12,21,30,39,48,57-heptaoxo-2,4,7,11,13,16,20,22,25,29,31,34,38,40,43,47,49,52,56,58,61-henicosaoxa-3λ5,12λ5,21λ5,30λ5,39λ5,48λ5,57λ5-heptaphosphaoctacyclo[58.3.0.06,10.015,19.024,28.033,37.042,46.051,55]trihexacontan-8-yl]pyrimidin-2-one

英文别名

——